Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest

Fig. 8

Cardiac and cerebral function evaluation after CA/CPR. Survival estimates by Kaplan–Meier in Vehicle and DATS@MION-PEG-LF groups within 30 d after CA/CPR (n = 30) (a); balance beam test scores (b) and neurological deficit scale scores (Emulsifying activity (OD500) and emulsion index IE24c) in Sham, Vehicle and DATS@MION-PEG-LF groups at 1 and 3 days after CA/CPR; representative M-mode images from individual groups evaluated at 3 days after CA/CPR (d); stroke volume (e), ejection fraction (f), and fractional shortening (g) measured by M-mode echocardiography at 1 d and 3 d after CA/CPR. *P < 0.05 compared between the Sham and the Vehicle Groups; #P < 0.05 compared between the DATS@MION-PEG-LF and the Vehicle Groups (mean ± SEM, n = 6)

Back to article page